PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.02
Bid: 0.019
Ask: 0.0199
Change: 0.0005 (2.64%)
Spread: 0.0009 (4.737%)
Open: 0.02
High: 0.02
Low: 0.0192
Prev. Close: 0.01895
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of New Shares and Total Voting Rights

10 Oct 2022 07:00

RNS Number : 3096C
Supply @ME Capital PLC
10 October 2022
 

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES.

10 October 2022

Supply@ME Capital plc

(the "Company" or "SYME")

Admission of 9,578,498,083 Secondary Admission Shares and 30,897,410 Open Offer Shares on exercise of Open Offer Warrants

Total Voting Rights

Words and expressions used but not defined in this announcement shall have the meanings given to them in the Company's prospectus published on 3 October 2022 (the "Prospectus"), which is available at: https://www.supplymecapital.com/wp-content/uploads/2022/10/SYME-Prospectus-Clean91.pdf.

SYME, the fintech business which provides an innovative fintech Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, announces that it has made applications to the FCA and the London Stock Exchange for admission to a Standard Listing and to trading on the Main Market ("Admission") of:

· 9,578,498,083 Secondary Admission Shares, comprising all remaining 1,230,000,000 Venus Mandatory Subscription Shares and all remaining 7,500,000,000 Venus Optional Subscription Shares, being issued at a price of 0.05 pence per share, raising gross proceeds for the Company of £4,365,000, and 848,498,083 Ordinary Shares issued to Venus on conversion of £417,500 Tranche A Venus CLNs plus accrued interest (inclusive of £61,500 in principal amount of Tranche A Venus CLNs to be issued and immediately converted, not attracting interest); and

· further to the issue of 320,855,008 Open Offer Warrants to certain Qualifying Shareholders who participated in the Open Offer, holders of Open Offer Warrants have elected to exercise 30,897,410 Open Offer Warrants. Accordingly, the Company will issue 30,897,410 new Open Offer Shares, and £20,084.24 will be received by the Company as a result of the exercise of such Open Offer Warrants,

with Admission expected to occur on or around 11 October 2022.

As detailed in the Prospectus, the Company will also issue to Venus a total of 2,115,000,000 Venus Warrants, comprising: 1 Venus Warrant for every 2 Venus Mandatory Subscription Shares; and 1 Venus Warrant for every 5 Venus Optional Subscription Shares. Such Venus Warrants each have an exercise price of 0.065 pence and are exercisable at any time up to 31 December 2025.

Accordingly, the Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, that on Admission, the Company's issued share capital will consist of 56,617,688,143 Ordinary Shares, each with one vote. There are no shares held in treasury. On Admission, the total number of voting rights in the Company will be 56,617,688,143 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries

Investors & Analysts:

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Media:

Nicole Louis, MHP, Nicole.Louis@mhpc.com

Orrick, Herrington & Sutcliffe (UK) LLP is acting as legal adviser to SYME.

Notes

SYME and its operating subsidiaries provide a Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEBLBFLBLEFBF
Date   Source Headline
19th Aug 20209:05 amRNSSecond Price Monitoring Extn
19th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20209:05 amRNSSecond Price Monitoring Extn
18th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSDirector/PDMR Shareholding
18th Aug 20207:00 amRNSHolding in Company
17th Aug 202011:05 amRNSSecond Price Monitoring Extn
17th Aug 202011:00 amRNSPrice Monitoring Extension
17th Aug 20209:05 amRNSSecond Price Monitoring Extn
17th Aug 20209:00 amRNSPrice Monitoring Extension
14th Aug 20209:05 amRNSSecond Price Monitoring Extn
14th Aug 20209:00 amRNSPrice Monitoring Extension
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:36 pmRNSPrice Monitoring Extension
13th Aug 20202:05 pmRNSSecond Price Monitoring Extn
13th Aug 20202:00 pmRNSPrice Monitoring Extension
12th Aug 202011:05 amRNSSecond Price Monitoring Extn
12th Aug 202011:00 amRNSPrice Monitoring Extension
11th Aug 20202:05 pmRNSSecond Price Monitoring Extn
11th Aug 20202:00 pmRNSPrice Monitoring Extension
11th Aug 20209:06 amRNSSecond Price Monitoring Extn
11th Aug 20209:00 amRNSPrice Monitoring Extension
10th Aug 20202:00 pmRNSPrice Monitoring Extension
10th Aug 20209:05 amRNSSecond Price Monitoring Extn
10th Aug 20209:00 amRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSMOU signed for first Pilot in Middle East region
6th Aug 20204:40 pmRNSSecond Price Monitoring Extn
6th Aug 20204:35 pmRNSPrice Monitoring Extension
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
29th Jul 202012:20 pmRNSHolding(s) in Company
29th Jul 202012:18 pmRNSDirector/PDMR Shareholding
27th Jul 20207:00 amRNSTrading Update
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSSenior Management Appointment
13th Jul 20202:06 pmRNSSecond Price Monitoring Extn
13th Jul 20202:00 pmRNSPrice Monitoring Extension
13th Jul 20209:00 amRNSPrice Monitoring Extension
9th Jul 20202:06 pmRNSSecond Price Monitoring Extn
9th Jul 20202:00 pmRNSPrice Monitoring Extension
9th Jul 20209:05 amRNSSecond Price Monitoring Extn
9th Jul 20209:00 amRNSPrice Monitoring Extension
8th Jul 20203:10 pmRNSHoldings in Company
8th Jul 20203:08 pmRNSHoldings in Company
7th Jul 20204:30 pmRNSDirector/PDMR Shareholding
7th Jul 20204:26 pmRNSDirector/PDMR Shareholding
7th Jul 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.